HKEX: 1244 - 3D Medicines Inc.

Yield per half year: -27.88%
Dividend yield: 0.00%
Sector: Healthcare

Reporting 3D Medicines Inc.

Reports

IFRS
Reporting Annual Quarterly
2022 2023
Финансовый отчет link link


Capitalization

IFRS
Reporting Annual
LTM 5 year average CAGR 5
Капитализация, млрд HK$
9.63
Выручка, млрд HK$
0.5674
Чистая прибыль, млрд HK$
-1.02
EV, млрд HK$
8.8
EBITDA, млрд HK$
-0.4328


Share

IFRS
Reporting Annual Quarterly
2022 2023 2024 2025 LTM 5 year average CAGR 5
EPS -22.32
Цена акции ао 42.5 7.64 3.02 3 3


Efficiency

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
ROA, % -23.03 5.11
ROS, % -179.77 -179.77 -179.77 -179.77 7.36
Рентаб EBITDA, % -77.67 6.06
Чистая рентаб, % -180.54 7.37
Operation Margin, % 0 0 0 0 9.85


Coefficients

IFRS
Reporting Annual
2023 2024 2025 LTM Industry average 5 year average CAGR 5
P/BV
9.43 2.99
P/S
2.76 9.92
P/FCF
0 0 0 0 6.18
E/P
-0.1059 -0.1059 -0.1059 -0.1059 0.04
EV/EBITDA
-8.57 -5.04
EV/Ebit
0 0 0
EV/S
15.51 15.51 15.51 15.51 46.67
EV/FCF
0 0 0 16.02
Debt/EBITDA
0 0 0 0 0.72
Netdebt/Ebitda
0 0 0 0 -0.64
Debt/Ratio
0 0 0 0 0.10
Debt/Equity
0 0 0 0 0.96
Debt/Net Income
0 0 0 0 1.14
Бета
9.1 1.48 4.19 4.19 -2.77
Индекс Альтмана
0 0 0 0 5.63


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 2.64
Дивиденды / прибыль, %
0 18.57


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual
2023 2024 CAGR 5
Персонал, чел
245 198